To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.

Rivian is already selling its product to customers, has new products in the pipeline, and is on its way to gross ...

And fewer businesses are experiencing shortages of labour that are holding back sales (Chart 6, green line ... of commercial operations for the Trans Mountain Expansion (TMX) pipeline and the expected ...

Positive upside is driven by the diverse portfolio of solutions to meet the clinical demand, and a pipeline of new projects ... companies by prescription sales and research/development spending ...

Herc Holdings is set for growth with capital plans and strong cash flows. Find out why HERC stock is a solid buy in renewable ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Surveying the next 12 months, J&J expects to chart roughly 3% sales growth to $91.3 billion ... to be able to enhance our portfolio, our pipeline.” The CEO pointed to the more than 40 deals ...